CClinicalTrials.gg
Status unknownNCT03453554Updated Oct 9, 2018

Evaluating a Digital Memory Notebook App to Improve Functional Independence

An interventional study of Digital Notebook app and Smart Home Prompting in Mild Cognitive Impairment, sponsored by Washington State University. Status unknown at 1 site in United States. Open to participants aged 40 Years and older. Per ClinicalTrials.gov, last updated 2018-10-09.

Sponsored by Washington State University · Not applicable, Interventional, and Supportive care

The sponsor has not verified this record recently (last verified Feb 2018), so the status shown — last known as Recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
40 Years and older
Sex
All
01

Study summary

This study will investigate the efficacy of a smart home / digital memory notebook (DMN) partnership that will allow for real-time intervention and thereby facilitate acquisition and use of the DMN to support everyday independence. The DMN is an app that is installed on a mobile tablet. The smart home technology discovers and recognizes generalizable activities and provides information about functional status and health-related variables for older adult participants. This study will examine how smart home prompts affect individuals' DMN use, ability to maintain activity routines, and overall wellbeing. Prompts will center on helping users organize and schedule daily activities, record both routine and uncommon events that may need to be remembered, and record activities performed and important associated event information (e.g., when, what, where). Prompting will help to promote everyday functional independence by encouraging frequent and regular notebook use and reducing memory difficulties. The DMN will also help to support functional independence by notifying individuals about appointments or prompting individuals to initiate important activities of daily living (e.g., take medications).

This study will also involve a machine learning technique to gain a better understanding of the contexts in which individuals adhere or do not adhere to the prompts. This activity-aware intervention will be deployed in the homes of older adults with memory difficulties, to assess the usability of the technology as well as to evaluate in a naturalistic setting the efficacy of the technology for increasing everyday functional independence and quality of life and decreasing care-partner burden. This contribution is significant because it will demonstrate that intelligent technologies can improve the efficacy of traditional memory rehabilitation techniques, extend functional independence, reduce caregiver burden, and improve quality of life.

Read the detailed description

Approximately 30 older adults who complain of memory problems will be recruited for this study. Over the course of six months, participants will complete questionnaires, open-ended questions, and cognitive and motor screens. Participants will also undergo training to learn to use a DMN to support daily activities and will continue to use the DMN for three months following training. Additionally, half of the participants' homes will be equipped with our "smart home in a box" technology that will support DMN use with context-aware prompting technology.

During month one, participants in both conditions will complete a cognitive and motor screen as well as questionnaires assessing depression, quality of life, coping, everyday memory, and functional abilities. Care-partners/informants (when available) will also complete the same questionnaires as well as an additional questionnaire about caregiver burden. The questionnaires will be administered monthly (6x total) for the duration of the study.

During month two, graduate students will train study participants to use the DMN using a training manual and workbook in 6-8 training sessions (depending on participants comfort with the DMN) over 3-4 weeks. Supervision will include review of audiotapes and use of a checklist to monitor fidelity of the training content and process. Participants and care-partners will also answer open-ended questions designed to help improve the DMN and its training procedure as well as the prompting technology and its integration with the DMN at each assessment period. In addition, participants and care-partners will complete questionnaires about their satisfaction and perception of ease of use of the DMN and interface as well as a questionnaire concerning likeability and cognitive demand.

During months three through five, data collection will continue. Participants in the smart home condition will use the DMN in conjunction with prompting technology for the third month, only the DMN for the fourth month, and again the DMN and prompting technology for the fifth month. Control participants will use only the DMN for all three months. Control participants will rely on traditional methods (e.g., time-based alarm cues, sticky notes) to support DMN use rather than activity-aware prompting technology.

During month six, participants will complete a post-test cognitive and motor screen identical to the initial screen. Participants will also complete the set of the previously described questionnaires and open-ended questions.

02

Conditions studied

  • Mild Cognitive Impairment

Keywords

  • technology
  • activities of daily living
  • everyday functioning
  • quality of life
  • memory impairment
03

Who can participate

Ages eligible
40 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • age 40+
  • memory problems documented by self-report
  • memory problems documented by cognitive data (i.e., memory testing > 1 std below expectations for age and education)
  • English speaking

Exclusion criteria

Exclusion Criteria:

  • unable to provide own informed consent
  • lack insight/awareness that are experiencing memory difficulties
04

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
30 participants (estimated)

Study arms

  • Experimental
    DMN/Smart Home Partnership

    Participants will learn how to use a digital memory notebook partnered with smart environment prompting technology to support everyday activities of daily living and reduce problems associated with memory deficits.

    Other: Digital Notebook app · Other: Smart Home Prompting

  • Active comparator
    Digital Memory Notebook app

    Participants will learn how to use a Digital Memory Notebook app to support everyday activities of daily living and reduce problems associated with memory deficits.

    Other: Digital Notebook app

Interventions

  • OtherDigital Notebook app

    Training in use of Digital Memory Notebook app

  • OtherSmart Home Prompting

    Smart-home sensor based activity-aware prompting to support digital memory notebook app use

05

What researchers measure

Primary outcomes

  1. Digital Memory Notebook Use

    Mean number of monthly DMN entries made and mean number of monthly DMN uses as measured continuously via the DMN app will be totaled to form a monthly DMN Memory Notebook use score.

    Time frame: Change will be assessed between monthly time points (1-, 2-, 3-, 4-, and 5-months).

  2. Quality of Life

    The Quality of Life-Alzheimer's disease (QOL-AD; Logsdon, 1996) scale will be used to measure quality of life and subjective well-being.

    Time frame: Total change in quality of life as measured by QOL-AD (range 13 [poor]-52 [best]) between baseline and monthly time points (1-, 2-, 3-, 4-, and 5-months).

  3. Activities of Daily Living

    The Instrumental Activities of Daily Living- Compensation (IADL-C; Schmitter-Edgecombe, Parsey, \& Lamb, 2014) will be used to provide an estimate of functional difficulties.

    Time frame: Total change in functional status as measured by IADL-C (range 27 [best]-216 [poor]) between baseline and monthly time points (1-, 2-, 3-, 4-, and 5-months).

  4. Caregiver Burden

    The Caregiver Burden Scale (CBS; Elmstahl et al., 1996) will be used to assess caregiver burden experienced by participants' care-partners.

    Time frame: Total change in caregiver burden as measured by CBS (range 0 [best]-96 [poor]) between baseline and monthly time points (1-, 2-, 3-, 4-, and 5-months).

Secondary outcomes

  1. Coping self-efficacy

    The Coping Self Efficacy Scale (CSES) assesses participants' perceived abilities to cope with life challenges.

    Time frame: Total change in coping self-efficacy as measured by CSES (range 0 [poor]-130 [best]) between baseline and monthly time points (1-, 2-, 3-, 4-, and 5-months)

  2. Cognitive functioning

    Neuropsychological assessment: Repeatable Battery for the Assessment of Neuropsychological Status (RBANS)

    Time frame: Total change in cognitive functioning as measured by RBANS (total score) at baseline and end of intervention (6 Months)

06

Study locations

1 of 1 sites recruiting
  • Washington State University - Pullman
    Pullman, Washington 99164-4820, United States
    Recruiting
07

References and documents

Publications

  • Schmitter-Edgecombe M, Brown K, Luna C, Chilton R, Sumida CA, Holder L, Cook D. Partnering a Compensatory Application with Activity-Aware Prompting to Improve Use in Individuals with Amnestic Mild Cognitive Impairment: A Randomized Controlled Pilot Clinical Trial. J Alzheimers Dis. 2022;85(1):73-90. doi: 10.3233/JAD-215022. PubMed 34776442 ↗
  • Chudoba LA, Church AS, Dahmen JB, Brown KD, Schmitter-Edgecombe M. The development of a manual-based digital memory notebook intervention with case study illustrations. Neuropsychol Rehabil. 2020 Oct;30(9):1829-1851. doi: 10.1080/09602011.2019.1611606. Epub 2019 May 3. PubMed 31046586 ↗

Individual participant data

Plan to share: No

08

Registry details

Key details

Study ID
NCT03453554
Lead sponsor
Washington State University
Collaborators
United States Department of Defense
Responsible party
Sponsor
First posted
Mar 5, 2018
Start date
Aug 1, 2018
Primary completion
Aug 30, 2021 (estimated)
Completion
Aug 30, 2021 (estimated)
Last update
Oct 9, 2018

Study contacts

Maureen Schmitter-Edgecombe, PhD
Contact
schmitter-e@wsu.edu
5093350170
Stephanie Saltness, B.S.
Contact
stephanie.salthness@wsu.edu
5093354033
Maureen Schmitter-Edgecombe, PhD
principal investigator · Washington State University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Feb 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion